Trial Profile
Mirtazapine Reduces ICD Appropriate Shocks in Cardioverter Implanted Patients With Depression and Anxiety.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2009
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary)
- Indications Anxiety; Arrhythmias; Depressive disorders
- Focus Pharmacodynamics
- 24 Aug 2009 New trial record